Certified by Founder Lodge
Eventide Asset Management
United States - Boston, MA
INVESTOR
1 Disclosed Funding Rounds $123,000,000
5 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Eventide Asset Management, LLC is a Boston-based investment adviser practicing "investing that makes the world rejoice®." Founded in 2008, Eventide's vision is to serve individuals, financia
| Company | Date | Round | Raised |
|---|---|---|---|
 Flare Therapeutics |
March, 23 ,2023 | Series B | $123,000,000 |
 Beta Bionics |
September, 04 ,2023 | Series D | $100,000,000 |
 Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
 Sudo Biosciences |
December, 21 ,2023 | Series B | $116,000,000 |
 PreciseDx |
August, 22 ,2024 | Series B | $20,700,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
